Skaraborg Hospital-Vaestra Goetalandsregionen

At Skaraborg Hospital-Vaestra Goetalandsregionen, clinical trials in Bacterial Infections and Mycoses and Virus Diseases focus on improving treatment for difficult infections and reducing complications from serious pathogens. Studies are exploring better antibiotic strategies for resistant urinary tract infections and bacteremia, as well as new ways to lessen the impact of Tick-Borne Encephalitis.

• New treatment options for resistant urinary tract infections and bloodstream infections
• Therapies aimed at improving outcomes in Staphylococcus aureus bacteremia
• Research on reducing brain injury during Tick-Borne Encephalitis infection

This area combines infection control, symptom reduction, and evaluation of therapies that may improve recovery in challenging infectious diseases.

The site has an active portfolio in Cardiovascular Diseases, Nutritional and Metabolic Diseases, and related kidney-heart conditions, with trials addressing stroke prevention, heart failure, and vascular risk reduction. Research includes patients with Atrial fibrillation, Heart failure with preserved ejection fraction, and high-risk atherosclerotic disease, often aiming to improve long-term protection against major cardiovascular events.

• Stroke prevention strategies in atrial fibrillation with advanced kidney disease
• Testing therapies to lower risk in high cardiovascular risk patients
• Evaluating treatments for heart failure and Takotsubo syndrome

These studies are designed to refine prevention and treatment approaches for serious heart and circulation disorders.

Clinical research in Nervous System Diseases and Eye Diseases at the hospital addresses urgent neurological conditions and vision-threatening disorders. Trials are studying recovery after acute ischemic stroke and Facial Nerve Palsy, while other work evaluates prevention of Retinopathy of Prematurity in vulnerable newborns.

• Improving functional recovery after acute ischemic stroke
• Testing treatments for Bells Palsy in children
• Preventing severe eye damage from Retinopathy of Prematurity

The research goal is to support earlier intervention and better outcomes in neurologic and ophthalmic care.

The oncology portfolio covers Neoplasms and Hemic and Lymphatic Diseases, with studies spanning Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Acute Myeloid Leukaemia, and Pediatric Cancer. These trials are focused on testing new treatment combinations, improving recurrence control, and strengthening anti-cancer immune responses.

• Evaluating new treatment approaches for advanced and metastatic cancers
• Improving survival and recurrence prevention in solid tumors
• Studying treatment effectiveness in acute myeloid leukaemia and childhood cancer

This research reflects a broad effort to improve cancer outcomes across both adult and pediatric populations.

Trials in Musculoskeletal Diseases, Hormonal diseases, and Female Urogenital Diseases and Pregnancy Complications address chronic inflammatory conditions, endocrine care, and obstetric management. The site is studying Rheumatoid arthritis, Type 1 diabetes, and labor induction, with the aim of improving symptom control, treatment adherence, and safety in routine care.

• Comparing treatment options for early rheumatoid arthritis
• Investigating immune-preserving therapy in newly diagnosed type 1 diabetes
• Assessing outpatient approaches for induction of labour

These studies support more personalized and practical care across autoimmune, hormonal, and maternity-related fields.

Research in Mental Disorders at the Infektionskliniken includes work on challenging psychiatric sexual disorders, combining psychological therapy with medical treatment to reduce harmful behavior. The trial program is aimed at improving risk management and supporting safer, more effective care for affected participants.

• Testing cognitive behavioral therapy approaches for sexual behavior disorders
• Evaluating whether added medical treatment can further reduce risk
• Studying behavioral interventions for prevention of harmful sexual offending

This area highlights the use of structured therapy to address complex mental health and behavioral concerns.